Table of Contents
ISRN Endocrinology
Volume 2012, Article ID 168264, 7 pages
http://dx.doi.org/10.5402/2012/168264
Clinical Study

Cardiac Autonomic Neuropathy Measured by Heart Rate Variability and Markers of Subclinical Atherosclerosis in Early Type 2 Diabetes

1Elderly Health Research Center, Endocrinology & Metabolism Research Center, Tehran University of Medical Sciences, Dr Shariati University Hospital, North Kargar Avenue, Tehran, Iran
2Tehran Heart Center, Tehran University of Medical Sciences, North Kargar Avenue, Tehran, Iran
3Endocrinology & Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran

Received 26 September 2012; Accepted 4 November 2012

Academic Editors: C. Anderwald, J. Pachucki, T.-H. Tung, and G. F. Wagner

Copyright © 2012 Hossein Fakhrzadeh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. I. Vinik and D. Ziegler, “Diabetic cardiovascular autonomic neuropathy,” Circulation, vol. 115, no. 3, pp. 387–397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Kempler, “Autonomic neuropathy: a marker of cardiovascular risk,” British Journal of Diabetes and Vascular Disease, vol. 3, no. 2, pp. 84–90, 2003. View at Google Scholar · View at Scopus
  3. D. J. Ewing, O. Boland, J. M. M. Neilson, C. G. Gho, and B. F. Clarke, “Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients,” Diabetologia, vol. 34, no. 3, pp. 182–185, 1991. View at Google Scholar · View at Scopus
  4. D. J. Ewing, C. N. Martyn, R. J. Young, and B. F. Clarke, “The value of cardiovascular autonomic function tests: 10 years experience in diabetes,” Diabetes Care, vol. 8, no. 5, pp. 491–498, 1985. View at Google Scholar · View at Scopus
  5. H. H. Osterhues, G. Grossmann, M. Kochs, and V. Hombach, “Heart-rate variability for discrimination of different types of neuropathy in patients with insulin-dependent diabetes mellitus,” Journal of Endocrinological Investigation, vol. 21, no. 1, pp. 24–30, 1998. View at Google Scholar · View at Scopus
  6. M. Chessa, G. Butera, G. A. Lanza et al., “Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy in children,” Herz, vol. 27, no. 8, pp. 785–790, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Tsuji, M. G. Larson, F. J. Venditti et al., “Impact of reduced heart rate variability on risk for cardiac events: the Framingham Heart Study,” Circulation, vol. 94, no. 11, pp. 2850–2855, 1996. View at Google Scholar · View at Scopus
  8. D. Liao, J. Cai, W. D. Rosamond et al., “Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study: The ARIC study,” American Journal of Epidemiology, vol. 145, no. 8, pp. 696–706, 1997. View at Google Scholar · View at Scopus
  9. J. M. Dekker, R. S. Crow, A. R. Folsom et al., “Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: The ARIC study,” Circulation, vol. 102, no. 11, pp. 1239–1244, 2000. View at Google Scholar · View at Scopus
  10. R. T. Hurst and R. W. Lee, “Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management,” Annals of internal medicine, vol. 139, no. 10, pp. 824–834, 2003. View at Google Scholar · View at Scopus
  11. P. W. F. Wilson, R. B. D'Agostino, D. Levy, A. M. Belanger, H. Silbershatz, and W. B. Kannel, “Prediction of coronary heart disease using risk factor categories,” Circulation, vol. 97, no. 18, pp. 1837–1847, 1998. View at Google Scholar · View at Scopus
  12. D. M. Lloyd-Jones, P. W. F. Wilson, M. G. Larson et al., “Framingham risk score and prediction of lifetime risk for coronary heart disease,” American Journal of Cardiology, vol. 94, no. 1, pp. 20–24, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Sibal, S. C. Agarwal, and P. D. Home, “Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes,” Diabetes, Metabolic Syndrome and Obesity, vol. 4, pp. 23–24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Lonn, “Use of carotid ultrasound to stratify risk,” Canadian Journal of Cardiology, vol. 17, no. 5, pp. 22A–25A, 2001. View at Google Scholar · View at Scopus
  15. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report,” The Journal of the American Medical Association, vol. 289, no. 19, pp. 2560–2572, 2003. View at Google Scholar
  16. W. Stanford, B. H. Thompson, T. L. Burns, S. D. Heery, and M. C. Burr, “Coronary artery calcium quantification at multi-detector row Helical CT versus electron-beam CT,” Radiology, vol. 230, no. 2, pp. 397–402, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. M. C. Corretti, T. J. Anderson, E. J. Benjamin et al., “Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force,” Journal of the American College of Cardiology, vol. 39, no. 2, pp. 257–265, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. “Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology,” Circulation, vol. 93, no. 5, pp. 1043–1065, 1996.
  19. U. R. Acharya, K. P. Joseph, N. Kannathal, C. M. Lim, and J. S. Suri, “Heart rate variability: a review,” Medical and Biological Engineering and Computing, vol. 44, no. 12, pp. 1031–1051, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Malliani, M. Pagani, F. Lombardi, and S. Cerutti, “Cardiovascular neural regulation explored in the frequency domain,” Circulation, vol. 84, no. 2, pp. 482–492, 1991. View at Google Scholar · View at Scopus
  21. A. J. M. Boulton, A. I. Vinik, J. C. Arezzo et al., “Diabetic neuropathies: a statement by the American Diabetes Association,” Diabetes Care, vol. 28, no. 4, pp. 956–962, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Freccero, H. Svensson, S. Bornmyr, P. Wollmer, and G. Sundkvist, “Sympathetic and parasympathetic neuropathy are frequent in both type 1 and type 2 diabetic patients,” Diabetes Care, vol. 27, no. 12, pp. 2936–2941, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Sucharita, G. Bantwal, J. Idiculla, V. Ayyar, and M. Vaz:, “Autonomic nervous system function in type 2 diabetes using conventional clinical autonomic tests, heart rate and blood pressure variability measures,” Indian Journal of Endocrinology and Metabolism, vol. 15, no. 3, pp. 198–203, 2011. View at Google Scholar
  24. N. Khatoon, B. Kumar, and M. Hazari, “Cardiovascular autonomic neuropathy in patients with diabetes mellitus,” International Journal of Pharma and Bio Sciences, vol. 1, no. 3, pp. 1–7, 2010. View at Google Scholar
  25. J. Gerritsen, J. M. Dekker, B. J. Tenvoorde et al., “Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: The hoorn study,” Diabetes Care, vol. 24, no. 10, pp. 1793–1798, 2001. View at Google Scholar · View at Scopus
  26. J. P. Singh, M. G. Larson, C. J. O'Donnell et al., “Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study),” American Journal of Cardiology, vol. 86, no. 3, pp. 309–312, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Liao, J. Cai, F. L. Brancati et al., “Association of vagal tone with serum insulin, glucose, and diabetes mellitus—The ARIC study,” Diabetes Research and Clinical Practice, vol. 30, no. 3, pp. 211–221, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Gottsäter, A. R. Ahlgren, S. Taimour, and G. Sundkvist, “Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes,” Clinical Autonomic Research, vol. 16, no. 3, pp. 228–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. N. H. Eller, B. Malmberg, and P. Bruhn, “Heart rate variability and intima media thickness,” International Journal of Behavioral Medicine, vol. 13, no. 3, pp. 201–213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Liao, M. Carnethon, G. W. Evans, W. E. Cascio, and G. Heiss, “Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the Atherosclerosis Risk in Communities (ARIC) study,” Diabetes, vol. 51, no. 12, pp. 3524–3531, 2002. View at Google Scholar · View at Scopus
  31. T. C. Rodrigues, J. Ehrlich, C. M. Hunter, G. L. Kinney, M. Rewers, and J. K. Snell-Bergeon, “Reduced heart rate variability predicts progression of coronary artery calcification in adults with type 1 diabetes and controls without diabetes,” Diabetes Technology and Therapeutics, vol. 12, no. 12, pp. 963–969, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. H. M. Colhoun, D. P. Francis, M. B. Rubens, S. Richard Underwood, and J. H. Fuller, “The association of heart-rate variability with cardiovascular risk factors and coronary artery calcification: a study in type 1 diabetic patients and the general population,” Diabetes Care, vol. 24, no. 6, pp. 1108–1114, 2001. View at Google Scholar · View at Scopus
  33. A. Pinter, T. Horvath, A. Sarkozi, and M. Kollai, “Relationship between heart rate variability and endothelial function in healthy subjects,” Autonomic Neuroscience, vol. 169, no. 2, pp. 107–112, 2012. View at Google Scholar
  34. J. Hayano, Y. Sakakibara, M. Yamada et al., “Decreased magnitude of heart rate spectral components in coronary artery disease: its relation to angiographic severity,” Circulation, vol. 81, no. 4, pp. 1217–1224, 1990. View at Google Scholar · View at Scopus
  35. C. Gautier, L. Stine, J. R. Jennings et al., “Reduced low-frequency heart rate variability relates to greater intimal-medial thickness of the carotid wall in two samples,” Coronary Artery Disease, vol. 18, no. 2, pp. 97–104, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Mäkimattila, A. Schlenzka, M. Mäntysaari et al., “Predictors of abnormal cardiovascular autonomic function measured by frequency domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes,” Diabetes Care, vol. 23, no. 11, pp. 1686–1693, 2000. View at Google Scholar · View at Scopus